Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, shared a post on LinkedIn:
“Thank you to Cancer Network for highlighting:
CAR-T Moves to the Front Line: Rethinking the Multiple Myeloma Sequence.
For decades, myeloma followed a script:
Induction – transplant – relapse – repeat.
What if we flipped the sequence?
CAR-T is no longer just salvage therapy. It may be the most powerful tool we have-used earlier.
Deep responses. MRD negativity across patients. A chance to rethink the entire treatment paradigm.
This isn’t just optimization – it’s a redefinition of how we treat myeloma.”
Other articles about Myeloma on OncoDaily.